Orion Portfolio Solutions’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.23M Buy
35,490
+5,610
+19% +$505K 0.03% 496
2024
Q4
$2.58M Sell
29,880
-985
-3% -$89.1K 0.03% 575
2024
Q3
$2.93M Sell
30,865
-991
-3% -$94.1K 0.03% 517
2024
Q2
$2.91M Sell
31,856
-1,111
-3% -$99.2K 0.03% 488
2024
Q1
$2.99M Sell
32,967
-1,844
-5% -$161K 0.03% 478
2023
Q4
$2.96M Sell
34,811
-3,227
-8% -$253K 0.03% 450
2023
Q3
$3.04M Sell
38,038
-2,290
-6% -$185K 0.04% 437
2023
Q2
$3.18M Sell
40,328
-1,292
-3% -$101K 0.03% 462
2023
Q1
$3.23M Sell
41,620
-8,320
-17% -$641K 0.04% 400
2022
Q4
$3.88M Sell
49,940
-1,886
-4% -$139K 0.14% 109
2022
Q3
$3.48M Buy
51,826
+61
+0.1% +$4.49K 0.14% 106
2022
Q2
$3.98M Sell
51,765
-3,347
-6% -$261K 0.16% 93
2022
Q1
$4.4M Sell
55,112
-322
-0.6% -$24.6K 0.15% 95
2021
Q4
$4.27M Sell
55,434
-1,113
-2% -$82.8K 0.14% 101
2021
Q3
$4.12M Sell
56,547
-1,536
-3% -$115K 0.15% 96
2021
Q2
$4.24M Sell
58,083
-1,838
-3% -$131K 0.17% 84
2021
Q1
$4.14M Sell
59,921
-4,179
-7% -$288K 0.18% 76
2020
Q4
$4.26M Sell
64,100
-4,003
-6% -$257K 0.2% 79
2020
Q3
$4.23M Sell
68,103
-9,578
-12% -$606K 0.22% 71
2020
Q2
$4.84M Sell
77,681
-94,981
-55% -$5.74M 0.26% 61
2020
Q1
$9.39M Buy
172,662
+686
+0.4% +$42.2K 0.65% 29
2019
Q4
$11M Buy
+171,976
New +$10.4M 0.87% 27

Other funds holding PPH

Orion Portfolio Solutions's PPH Position: Q1 2025 in Review

Orion Portfolio Solutions increased its VanEck Pharmaceutical ETF (PPH) stake by 19% in Q1 2025, buying an estimated $505K and bringing the position to 35,490 shares worth $3.23M. The position accounts for 0.03% of the portfolio, ranked #496.

Orion Portfolio Solutions first reported a position in PPH in Q4 2019 and has held it in 22 quarters since. The position peaked at $11M in Q4 2019. 136 funds tracked by Wall St. Rank hold PPH as of Q1 2025.

  • Orion Portfolio Solutions held 35,490 shares of VanEck Pharmaceutical ETF worth $3.23M as of Q1 2025.
  • Orion Portfolio Solutions bought 5,610 VanEck Pharmaceutical ETF shares in Q1 2025, an estimated $505K.
  • VanEck Pharmaceutical ETF made up 0.03% of Orion Portfolio Solutions's portfolio in Q1 2025, its #496 holding.
  • Orion Portfolio Solutions first reported a position in VanEck Pharmaceutical ETF in Q4 2019 and has held it in 22 quarters since.
  • Orion Portfolio Solutions's VanEck Pharmaceutical ETF position peaked at $11M in Q4 2019.
  • 136 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.